Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China Touyun Tech Group ( (HK:1332) ) just unveiled an announcement.
Touyun Biotech Group Limited has announced a series of strategic measures to address its liquidity challenges and improve its financial position, as outlined in its 2024 Annual Report. The company is actively launching new health products to expand its market presence and has secured financial support through loans and shareholder agreements to defer debt repayments. Additionally, the company is exploring the sale of non-core assets to bolster working capital, with recent disposals expected to yield significant gains.
More about China Touyun Tech Group
Touyun Biotech Group Limited operates in the biotech industry, focusing on developing and marketing health products. The company aims to expand its customer base and revenue streams by launching new health products, capitalizing on the growing health consciousness among the population.
Average Trading Volume: 711,927
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$244.1M
Find detailed analytics on 1332 stock on TipRanks’ Stock Analysis page.